Literature DB >> 3028724

Depression in an animal model: focus on the locus ceruleus.

J M Weiss, P G Simson.   

Abstract

When rats are exposed to highly stressful events over which they have no control, they subsequently show many of the symptoms seen in depression in humans. In the attempt to discover neurochemical factors underlying depression, the neurochemical basis of stress-induced behavioural depression in rats has been studied extensively. Initial research (1968-1976) indicated that behavioural depression in this model was produced by alteration of noradrenaline (NA) concentrations in the brain. More recent research has indicated that the critical change may be a large depletion of NA in the locus ceruleus (LC). Behavioural depression may result when such NA depletion is sufficient to reduce NA release in the LC region, leading to a 'functional blockade' of inhibitory alpha 2-receptors in that brain region. Studies have now shown that behavioural depression after uncontrollable shock can be mimicked by pharmacological blockade of alpha 2-receptors in the LC region. Conversely, behavioural depression can be eliminated by either infusion of clonidine into the LC to replace at the alpha 2-receptors the NA depleted after uncontrollable shock, or infusion of pargyline into the LC to prevent the depletion of NA that otherwise follows uncontrollable shock. If alpha 2-receptors are functionally blocked in depression, then release of NA in regions innervated by the LC should be increased and stimulation of postsynaptic adrenoceptors outside the LC should be higher than normal. Thus, higher-than-normal stimulation of postsynaptic NA receptors should also produce behavioural depression; this has been demonstrated.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3028724     DOI: 10.1002/9780470513361.ch11

Source DB:  PubMed          Journal:  Ciba Found Symp        ISSN: 0300-5208


  19 in total

Review 1.  Future directions for brain, behavior, and the immune system.

Authors:  M Stein
Journal:  Bull N Y Acad Med       Date:  1992-07

2.  The alpha-2B adrenoceptor in the paraventricular thalamic nucleus is persistently upregulated by chronic psychosocial stress.

Authors:  U Heilbronner; M van Kampen; G Flügge
Journal:  Cell Mol Neurobiol       Date:  2004-12       Impact factor: 5.046

3.  Enhanced emotion-induced amnesia in borderline personality disorder.

Authors:  René Hurlemann; Barbara Hawellek; Wolfgang Maier; Raymond J Dolan
Journal:  Psychol Med       Date:  2007-01-16       Impact factor: 7.723

Review 4.  Exercise, learned helplessness, and the stress-resistant brain.

Authors:  Benjamin N Greenwood; Monika Fleshner
Journal:  Neuromolecular Med       Date:  2008-02-26       Impact factor: 3.843

5.  Activation of the ventral medial prefrontal cortex during an uncontrollable stressor reproduces both the immediate and long-term protective effects of behavioral control.

Authors:  J Amat; E Paul; L R Watkins; S F Maier
Journal:  Neuroscience       Date:  2008-04-18       Impact factor: 3.590

6.  Catecholamine effects upon rat hypothalamic corticotropin-releasing hormone secretion in vitro.

Authors:  A E Calogero; W T Gallucci; G P Chrousos; P W Gold
Journal:  J Clin Invest       Date:  1988-09       Impact factor: 14.808

7.  Gender-related characteristics of responding to prolonged psychoemotional stress in mice.

Authors:  D F Avgustinovich; I L Kovalenko
Journal:  Neurosci Behav Physiol       Date:  2010-02-10

8.  Stress-induced alterations of immunity in hypophysectomized rats.

Authors:  S E Keller; S J Schleifer; A S Liotta; R N Bond; N Farhoody; M Stein
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

9.  Stressor controllability modulates fear extinction in humans.

Authors:  Catherine A Hartley; Alyson Gorun; Marianne C Reddan; Franchesca Ramirez; Elizabeth A Phelps
Journal:  Neurobiol Learn Mem       Date:  2013-12-11       Impact factor: 2.877

10.  Elevated levels of the NR2C subunit of the NMDA receptor in the locus coeruleus in depression.

Authors:  Beata Karolewicz; Craig A Stockmeier; Gregory A Ordway
Journal:  Neuropsychopharmacology       Date:  2005-08       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.